Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study

Anticancer Research

Volumn 23, Issue 2 C, 2003, Pages 1803-1809

  Cigolari, Silvio ^a   Curcio, Carlo ^b   Maiorino, Alfonso ^b   Sessa, Raffaele ^b   Cioffi, Angela ^a   Massimo, Mario ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MONALDI HOSPITAL   (Italy)

Author keywords

Multimodality therapy; Neoadjuvant chemotherapy; Non small cell lung cancer; Stage IIIB disease; Surgery

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT COMPLIANCE; REMISSION INDUCTION; VINBLASTINE;

EID: 0037862105     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
2. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R and Rotman M: Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 59: 1874-1881, 1987.
3. Feld R, Rubinstein L and Thomas P: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. J Natl Cancer Inst 85: 299-306, 1993.
4. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Mueller MR, Stahl M, Flasshove M, Budach V, Grschuchna D, Konietzko N, Sack H and Seeber S: Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II study. J Clin Oncol 16: 622-634, 1998.
5. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr and Green MR: Improved survival in stage III NSCLC: seven year follow-up of CALGB 8433. J Natl Cancer Inst 88: 1210-1215, 1996.
6. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, Lacombe-terrier MJ, Douillard JY and Laplanche A: Radiotherapy alone versus combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer: first analysis of a randomized trial of 353 patients. J Natl Cancer Inst 83: 417-423, 1991.
7. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311: 899-909, 1995.
8. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, De Caro L, Chasen M and McGavran M: A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable IIIA non-small cell lung cancer. J Natl Cancer Inst 86: 673-680, 1994.
9. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J and Olazabal A: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330: 153-158, 1994.
10. Shepherd FA: Induction chemotherapy for locally advanced non-small cell lung cancer. Ann Thorac Surg 55: 1585-1592, 1993.
11. Bunn PA: The expanding role of cisplatin in the treatment of non-small cell lung cancer. Semin Oncol 16 (suppl 6): 16-21, 1989.
12. Depierre A, Chastang C, Quoix E, Lebeau B, Blanchon F, Paillot N, Lemarie E, Milleron B, Moro D and Clavier J: Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol 5: 37-42, 1994.
13. Furuse K, Fukuoka M, Kuba M, Yamori S, Nakai Y, Negoro S, Katagami N, Takada Y, Kinuwaki E, Kawahara M, Kubota K, Sakuma A and Niitani H: Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group. Ann Oncol 7: 815-820, 1996.
14. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P and Tursz T: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12: 360-367, 1994.
15. Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Spiridonidis CH, Baker LH, Albain KS, Kelly K, Taylort SA, Gandara DR and Livingstone RB: Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 16: 2459-2465, 1998.
16. Miller AB, Hoogstraten B, Staquet M and Winkler A: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
17. Fleming TR: One-sample multiple testing procedure for phase II clinical trials. Biometrics 38: 143-145, 1982.
18. Green MR, Cox JD, Ardizzoni A, Arriagada R, Bureau G, Darwish S, Deneffe G, Fukuoka M, Joseph D and Komaki R: Endpoints for multimodal clinical trials in stage III non-small cell lung cancer: A consensus report. Lung Cancer 11 (suppl 3): S11-S13, 1994.
19. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
20. Rusch VW, Albain KS, Crowley JJ, Rice TW, Lonchyna V, McKenna R Jr, Stelzer K and Livingstone RB: Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Ann Thorac Surg 58: 290-295, 1994.
21. Grunenwald DH, Andre F, Le Pechoux C, Girard P, Lamer C, Laplanche A, Tarayre M, Arriagada R and Le Chevalier T: Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122: 796-802, 2001.
22. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT 3rd, Weick JK, Lonchyna VA, Presant CA, McKenna RJ and Gandara DR: Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880-1892, 1995.
23. Thomas M, Rübe Ch, Semik M, von Eiff M, Freitag L, Macha HN, Wagner W, Klinke F, Scheld HH, Willich N, Berdel WE and Junker K: Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 17: 1185-1193, 1999.
24. Sauvaget J, Rebischung J and Vannetzel J: Phase III study of neoadjuvant MVP versus MVP plus chemo-radiotherapy in stage III NSCLC. Proc Am Soc Clin Oncol 19: 495a (abstr), 2000.
25. Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J and De Gregorio MW: Cisplatin dose intensity in non-small cell lung cancer: phase II results of day 1 and day 8 high-dose regimen. J Natl Cancer Inst 81: 790-794, 1989.
26. Gralla RJ, Casper ES, Kelsen DP, Braun DW Jr, Dukeman ME, Martini N, Young CW and Golbey RB: Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: a randomized trial investigating two dosage schedules. Ann Intern Med 95: 414-420, 1981.
27. Gandara DR, Crowley J, Livingston RB, Perez EA, Taylor CW, Weiss G, Neefe JR, Hutchins LF, Roach RW and Grunberg SM: Evaluation of cisplatin intensity in metastatic non-small cell lung cancer: a phase III study of the Southwest Oncology Group. J Clin Oncol 11: 873-878, 1993.
28. Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, Richez M, Ravez P, Vandermoten G and Thiriaux J: A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861. J Clin Oncol 8: 1556-1562, 1990.
29. Byhardt RW: Nonsurgical treatment of locally advanced non-small-cell lung cancer. Fall Education Conference pp. 106-111, 1999.